Comments on: Cell Therapeutics Taps Stock Market Again, Seeks $40M or More http://www.xconomy.com/seattle/2009/07/22/cell-therapeutics-taps-stock-market-again-seeks-40m-or-more/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 09:14:03 +0000 hourly 1 http://wordpress.org/?v=3.0.4 By: Bristol-Myers Squibb Strikes $2.1 billion Deal for Medarex « The Cross-Border Biotech Blog http://www.xconomy.com/seattle/2009/07/22/cell-therapeutics-taps-stock-market-again-seeks-40m-or-more/comment-page-1/#comment-71926 Bristol-Myers Squibb Strikes $2.1 billion Deal for Medarex « The Cross-Border Biotech Blog Thu, 23 Jul 2009 15:50:54 +0000 http://www.xconomy.com/?p=34680#comment-71926 [...] next“ in what DailyFinance calls ”[t]he heated-up biotech sector,” and Cell Therapeutics is in the market looking to sell $40 million or so of [...] [...] next“ in what DailyFinance calls ”[t]he heated-up biotech sector,” and Cell Therapeutics is in the market looking to sell $40 million or so of [...]

]]> By: Cell Therapeutics out to raise $40M - FierceBiotech http://www.xconomy.com/seattle/2009/07/22/cell-therapeutics-taps-stock-market-again-seeks-40m-or-more/comment-page-1/#comment-71921 Cell Therapeutics out to raise $40M - FierceBiotech Thu, 23 Jul 2009 14:49:53 +0000 http://www.xconomy.com/?p=34680#comment-71921 [...] Cell Therapeutics is looking to raise around $40 million through the sale of stock as it seeks an FDA approval on its latest cancer therapy. Xconomy notes the Seattle-based company has raised $1.3 billion over 18 years without consistently turning a profit. Report [...] [...] Cell Therapeutics is looking to raise around $40 million through the sale of stock as it seeks an FDA approval on its latest cancer therapy. Xconomy notes the Seattle-based company has raised $1.3 billion over 18 years without consistently turning a profit. Report [...]

]]>